Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ventyx Biosciences, Inc. - Common Stock
(NQ:
VTYX
)
1.700
-0.110 (-6.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ventyx Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Earnings Scheduled For November 3, 2022
November 03, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Via
Benzinga
Earnings Outlook For Ventyx Biosciences
November 02, 2022
Ventyx Biosciences (NASDAQ:VTYX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Ventyx...
Via
Benzinga
Stifel Maintains Buy Rating for Ventyx Biosciences: Here's What You Need To Know
September 16, 2022
Stifel has decided to maintain its Buy rating of Ventyx Biosciences (NASDAQ:VTYX) and raise its price target from $45.00 to $53.00. Shares of Ventyx Biosciences are trading up 4.1% over the last 24...
Via
Benzinga
Dow To $45? Here Are 5 Other Price Target Changes For Tuesday
September 13, 2022
Jefferies cut the price target on Dow Inc. (NYSE: DOW) from $71 to $45. Jefferies analyst Laurence Alexander also downgraded the stock from Buy to Hold. Dow shares fell 0.8% to $50.55 in pre-market...
Via
Benzinga
NIO, Lucid Group And Other Big Gainers From Monday
September 13, 2022
U.S. stocks closed higher with the Dow Jones surging more than 200 points on Monday. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
S&P 500 Rises 1%, InMed Pharmaceuticals Shares Spike Higher
September 12, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Monday.
Via
Benzinga
This Inflammatory Disease Focused Stock Is Well Positioned For $12B Crohn's Disease Market
August 16, 2022
Via
Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
Via
Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Via
Benzinga
Dow Jumps 250 Points; Crude Oil Rises Over 1%
September 12, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Monday.
Via
Benzinga
ASTS Stock: What to Know as AST SpaceMobile’s BlueWalker 3 Reaches Orbit
September 12, 2022
AST SpaceMobile (ASTS) stock is in the news Monday as the company's BlueWalker 3 satellite entered Earth's orbit over the weekend.
Via
InvestorPlace
Why Is Ventyx Biosciences (VTYX) Stock Up 70% Today?
September 12, 2022
Ventyx Biosciences (VTYX) stock is rocketing higher on Monday after Oppenheimer analyst Jeff Jones provided an update on the shares.
Via
InvestorPlace
US Stocks Open Higher, Nasdaq Surges Over 100 Points
September 12, 2022
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 12, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
September 01, 2022
Upgrades
Via
Benzinga
4 Analysts Have This to Say About Ventyx Biosciences
September 01, 2022
Over the past 3 months, 4 analysts have published their opinion on Ventyx Biosciences (NASDAQ:VTYX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
Nasdaq Falls 75 Points; Ventyx Biosciences Shares Spike Higher
August 16, 2022
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 75 points on Tuesday.
Via
Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
August 17, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 16, 2022
Via
Benzinga
Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session
August 16, 2022
Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via
Benzinga
Ventyx Sees Initiation Of Mid-Stage Psoriasis Study In Q4 2022 Following Positive Data From Initial-Stage Study
August 15, 2022
Ventyx Biosciences (NASDAQ: VTYX) announced positive data from the Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) trial of VTX958, a novel and selective allosteric TYK2...
Via
Benzinga
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
July 12, 2022
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Via
Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
May 09, 2022
Upgrades
Via
Benzinga
71 Biggest Movers From Yesterday
April 27, 2022
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022
March 31, 2022
Upgrades
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 22, 2022
During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.